Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes

References

• American Lung AssociationTrends in asthma morbidity and mortality Epidemiology and Statistics Unit, Research and Program Services Division. 2010 Feb report. Available at: http://www.lungusa.org/finding-cures/our-research/trend-reports/asthma-trend-report.pdf. Accessed Aug 11 2010.
   Google Scholar
• WertzDAPollackMRodgersKBohnRLSaccoPSullivanSDImpact of asthma control on sleep, attendance at work, normal activities, and disease burdenAnn Allergy Asthma Immunol2010105211812320674821
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program Expert panel report 3: guidelines for the diagnosis and management of asthma – Full report. NIH Publication Number 08-4051, 2007.
   Google Scholar
• ReddelHKTaylorDRBatemanEDAn official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practiceAm J Respir Crit Care Med20091801599919535666
   PubMed Web of Science ®Google Scholar
• Symbicort® Inhalation Aerosol (budesonide/formoterol pMDI) prescribing information Available at: http://www1.astrazeneca-us.com/pi/symbicort.pdf. Accessed Jun 23 2010.
   Google Scholar
• Symbicort Turbohaler (budesonide/formoterol DPI) prescribing information Available at: http://www.medicines.org.uk/EMC/medicine/4821/SPC/Symbicort+Turbohaler+100+6+Inhalation+powder/. Accessed Dec 1 2010.
   Google Scholar
• SzeflerSJEigenHBudesonide inhalation suspension: a nebulized corticosteroid for persistent asthmaJ Allergy Clin Immunol2002109473074211941331
   PubMed Web of Science ®Google Scholar
• SzeflerSJPharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroidJ Allergy Clin Immunol1999104S175S183
   PubMed Web of Science ®Google Scholar
• BergerWEThe use of inhaled formoterol in the treatment of asthmaAnn Allergy Asthma Immunol2006971243316892777
   PubMed Web of Science ®Google Scholar
• JeppssonABKällströmBLWaldeckBStudies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitroPharmacol Toxicol19927142722771360657
   PubMedGoogle Scholar
• PalmqvistMPerssonGLazerLRosenborgJLarssonPLötvallJInhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potencyEur Respir J19971011248424899426083
   PubMed Web of Science ®Google Scholar
• GoldsmithDRKeatingGMBudesonide/formoterol: a review of its use in asthmaDrugs200464141597161815233594
   PubMed Web of Science ®Google Scholar
• UsmaniOSItoKManeechoetesuwanKGlucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapyAm J Respir Crit Care Med2005172670471215860753
   PubMed Web of Science ®Google Scholar
• McCormackPLLyseng-WilliamsonKABudesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthmaDrugs200767162407243117983258
   PubMed Web of Science ®Google Scholar
• OdderaSSilvestriMTestiRRossiGASalmeterol enhances the inhibitor activity of dexamethasone on allergen-induced blood mononuclear cell activationRespiration19986531992049670302
   PubMed Web of Science ®Google Scholar
• BarnesPJScientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroidsEur Respir J200219118219111843317
   PubMed Web of Science ®Google Scholar
• TrondeAGillenMBorgströmLLötvallJAnkerstJPharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPDJ Clin Pharmacol200848111300130818974284
   PubMed Web of Science ®Google Scholar
• EklundATrondeAJohannes-HellbergIGillenMBorgströmLPharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adultsBiopharm Drug Dispos200829738239518623040
   PubMed Web of Science ®Google Scholar
• NoonanMRosenwasserLJMartinPO’BrienCDO’DowdLEfficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trialDrugs200666172235225417137405
   PubMed Web of Science ®Google Scholar
• CorrenJKorenblatPEMillerCJO’BrienCOMezzanotteWSTwelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthmaClin Ther200729582384317697902
   PubMed Web of Science ®Google Scholar
• PetersSPPrennerBMMezzanotteWSMartinPO’BrienCDLong-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patientsAllergy Asthma Proc200829549951618694544
   PubMed Web of Science ®Google Scholar
• KerwinEMOppenheimerJJLaForceCEfficacy and tolerability of once-daily budesonide/formoterol pressurized meted-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/formoterol dosingAnn Allergy Asthma Immunol20091031627219663129
   PubMed Web of Science ®Google Scholar
• BergerWEBleeckerERO’DowdDMillerCJMezzanotteWEfficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthmaAllergy Asthma Proc2010311495920167145
   PubMed Web of Science ®Google Scholar
• BusseWWShahSSSomervilleLParasuramanBMartinPGoldmanMComparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patientsJ Allergy Clin Immunol200812161407141418455221
   PubMed Web of Science ®Google Scholar
• MurphyKPearlmanDSUryniakTO’BrienCDMezzanotteWSEfficacy of budesonide/formoterol pressurized metered-dose inhaler (BUD/FM pMDI) in children with asthma previously treated with inhaled corticosteroids (ICSs)Am J Respir Crit Care Med.2008177A710 [Abstract]
   Google Scholar
• MoriceAHPetersonSBeckmanOKubovaZEfficacy and safety of a new pressurized metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence studyPul Pharmacol Ther2008211152159
   Web of Science ®Google Scholar
• BergerWELefleinJGGellerDEThe safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in childrenAllergy Asthma Proc2010311263920167143
   PubMed Web of Science ®Google Scholar
• EidNSNoonanMJChippsBParasuramanBMillerCJO’BrienCDOnce- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthmaPediatrics20101263e565e57520713475
   PubMed Web of Science ®Google Scholar
• KaiserHParasuramanBBoggsRMillerCJLeidyNKO’DowdLOnset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroidsAnn Allergy Asthma Immunol2008101329530318814453
   PubMed Web of Science ®Google Scholar
• O’ConnorRDPatrickDLParasuramanBMartinPGoldmanMComparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthmaJ Asthma201047221722320170333
   PubMed Web of Science ®Google Scholar
• ChervinskyPBakerJBenschGPatient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhalerAnn Allergy Asthma Immunol2008101546347319055199
   PubMed Web of Science ®Google Scholar
• MurphyKNelsonHParasuramanBBoggsRMillerCO’DowdLThe effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthmaCurr Med Res Opin200824387989418267051
   PubMed Web of Science ®Google Scholar
• BenderBGLongAParasuramanBTranZVFactors influencing patient decisions about the use of asthma controller medicationAnn Allergy Asthma Immunol200798432232817458427
   PubMed Web of Science ®Google Scholar
• JohanssonGStällbergBTornlingGAsthma treatment preference study: a conjoint analysis of preferred drug treatmentsChest2004125391692315006950
   PubMed Web of Science ®Google Scholar
• HampelFCMartinPMezzanotteWSEarly bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroidsJ Asthma200845426527218446589
   PubMed Web of Science ®Google Scholar
• LeidyNKMathiasSDParasuramanBMPatrikDLPathakDDevelopment and validation of an onset of effect questionnaire for patients with asthmaAllergy Asthma Proc200829659059918775104
   PubMed Web of Science ®Google Scholar
• HauberABMohamedAFJohnsonRMeddisDWagnerSO’DowdLQuantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agnoist maintenance medicationsAllergy Asthma Proc200930213914719463204
   PubMed Web of Science ®Google Scholar
• HardingGLeidyNKMeddisDKleinmanLWagnerSO’BrienCDInterpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panelCurr Med Res Opin20092561563157119445651
   PubMed Web of Science ®Google Scholar
• MathiasSDWarrneEHColwellHHSungJCYA new treatment satisfaction measure for asthmatics: a validation studyQual Life Res20009787388211297030
   PubMed Web of Science ®Google Scholar
• KorenblatPERosenwasserLJBudesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthmaAllergy Asthma Proc201031319020220482961
   PubMed Web of Science ®Google Scholar
• MartinMLPatrickDLBushnellDMMeltzeEOGutierrezBParasuramanBDevelopment of the asthma treatment satisfaction measureCurr Med Res Opin200925102495250619689222
   PubMed Web of Science ®Google Scholar
• JuniperEFBuistASCoxFMFerriePKKingDRValidation of a standardized version of the asthma quality of life questionnaireChest19991151265127010334138
   PubMed Web of Science ®Google Scholar
• JuniperEFGuyattGHEpsteinRSFerriePJJaeschkeRHillerTKEvaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trialsThorax199247276831549827
   PubMed Web of Science ®Google Scholar
• JuniperEFGuyattGHWillanAGriffithLEDetermining a minimal important change in a disease-specific Quality of Life QuestionnaireJ Clin Epidemiol199447181878283197
   PubMed Web of Science ®Google Scholar
• JuniperEFGuyattGHFeenyDHFerriePJGriffithLETownsendMMeasuring quality of life in children with asthmaQual Life Res19965135468901365
   PubMed Web of Science ®Google Scholar
• JuniperEFGuyattGHFeenyDHFerriePJGriffithLETownsendMMeasuring quality of life in the parents of children with asthmaQual Life Res19965127348901364
   PubMed Web of Science ®Google Scholar
• JansonCGislasonTBomanGHettaJRoosBESleep disturbances in patients with asthmaRepir Med19908413742
   PubMed Web of Science ®Google Scholar
• HaysRDStewardALSleep measures: definitions and issuesStewardALWareJEMeasuring Functioning and Well-being: The Medical Outcomes Study ApproachDurham, NCDuke University Press1992235259
   Google Scholar
• FDA Drug Safety Communication: New safety requirements for long-acting inhaled asthma medications called Long-Acting Beta-Agonists (LABAs)2010218 Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm. Accessed Aug 13 2010.
   Google Scholar
• FDA Drug Safety Communication: Drug labels now contain updated recommendations on the appropriate use of long-acting inhaled asthma medications called Long-Acting Beta-Agonists (LABAs)201062 Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm213836.htm. Accessed Aug 13 2010.
   Google Scholar
• LevensonMLong-acting beta-agonists and adverse asthma events meta-analysis: statistical briefing package for joint meeting of the Pulmonary-Allergy Drugs Advisory Committee, Drug Safety and Risk Management Advisory Committee, and Pediatric Advisory Committee on 2008 Dec 10–11 http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4398b1-01-FDA.pdf. Accessed Aug 13 2010.
   Google Scholar
• NelsonHSWeissSTBleeckerERYanceySWDorinskyPMThe salmeterol multicenter asthma research trialChest20061291152616424409
   PubMed Web of Science ®Google Scholar
• CastleWFullerRHallJPalmerJSerevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatmentBMJ19933066884103410378098238
   PubMed Web of Science ®Google Scholar
• CatesCJCatesMJRegular treatment with salmeterol for chronic asthma: serious adverse eventsCochrane Database Syst Rev.20087163CD00636318646149
   PubMed Web of Science ®Google Scholar
• BatemanENelsonHBousquetJMeta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related eventsAnn Intern Med20081491334218523132
   PubMed Web of Science ®Google Scholar
• SearsMROttossonARadnerFLong-acting beta-agonists: a review of formoterol safety data from asthma clinical trialsEur Respir J2009331213218768573
   PubMed Web of Science ®Google Scholar
• NelsonHSBonuccelliCRadnerFSafety of formoterol in patients with asthma: combined analysis of data from double-blind, randomized controlled trialsJ Allergy Clin Immunol2010125239039620159250
   PubMed Web of Science ®Google Scholar
• SalpeterSRWallAJBuckleyNSLong-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma eventsAm J Med20101234322328.e220176343
   PubMed Web of Science ®Google Scholar
• SalpeterSRBuckleyNSOrmistonTMSalpeterEEMeta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deathsAnn Intern Med20061441290491216754916
   PubMed Web of Science ®Google Scholar
• JaeschkeRO’ByrnePMMejzaFThe safety of long acting beta agonists among patients with asthma using inhaled corticosteroids: systematic review and meta-analysisAm J Respir Crit Care Med2008178101009101618776152
   PubMed Web of Science ®Google Scholar
• PriceJFRadnerFLenneyWLindbergBSafety of formoterol in children and adolescents: experience from asthma clinical trialsArch Dis Child201095121047105321030368
   PubMed Web of Science ®Google Scholar
• WijesingheMWeatherallMPerrinKHarwoodMBeasleyRRisk of mortality associated with formoterol: a systematic review and meta-analysisEur Respir J200934480381119797669
   PubMed Web of Science ®Google Scholar
• ButlandBKAndersonHRCatesCJBronchodilator treatment and asthma death: a new analysis of a British case-control studyRespir Med20101027 [Epub ahead of print]
   Web of Science ®Google Scholar
• ChowdhuryBADal PanGThe FDA and safe use of long-acting beta-agonists in the treatment of asthmaN Engl J Med2010362131169117120181964
   PubMed Web of Science ®Google Scholar
• Global Initiative for AsthmaGlobal Strategy for Asthma Management and Prevention Updated 2009. Available at: http://www.ginasthma.org. Accessed Dec 13 2010.
   Google Scholar